Guardant Health, Inc. Common Stock

GH XNAS • SERVICES-MEDICAL LABORATORIES

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

17B

Short interest (May 15)

9.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.38%

↑ 38.8%

Available Shares

↓ 40.0%

Price Chart

Company Overview

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Company Info

Exchange: NASDAQ

Industry: SERVICES-MEDICAL LABORATORIES

CIK: 0001576280

Asset Type: CS

Market Data

Market Cap: $17,260,532,757

Employees: 2,506

Status: Active

Short Interest

Current Borrow Fee 0.38%

Range: 0.38% - 0.39%

Available Shares 1M

Range: 1.4M - 1.4M

Recent Changes

Fee Change: ↓ 3.3%

Available Change: ↓ 9.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime